ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX)

1,45
-0,01
( -0,68% )
Aktualisiert: 16:37:33

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
1,45
Gebot
1,41
Fragen
1,46
Volumen
20.970
1,40 Tagesbereich 1,46
0,87 52-Wochen-Bereich 3,88
Marktkapitalisierung
Handelsende
1,46
Handelsbeginn
1,46
Letzte Trade
200
@
1.45
Letzter Handelszeitpunkt
16:37:35
Finanzvolumen
US$ 30.364
VWAP
1,448
Durchschnittliches Volumen (3 Mio.)
132.081
Ausgegebene Aktien
29.878.890
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,67
Gewinn pro Aktie (EPS)
-2,17
Erlöse
-
Nettogewinn
-64,73M

Über AN2 Therapeutics Inc

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Dover, Delaware, USA
Gegründet
-
AN2 Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANTX. The last closing price for AN2 Therapeutics was US$1,46. Over the last year, AN2 Therapeutics shares have traded in a share price range of US$ 0,87 to US$ 3,88.

AN2 Therapeutics currently has 29.878.890 shares in issue. The market capitalisation of AN2 Therapeutics is US$43,62 million. AN2 Therapeutics has a price to earnings ratio (PE ratio) of -0.67.

ANTX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.17.407407407411.351.4651.34543911.41520959CS
40.3127.19298245611.141.4651.0851370391.20932917CS
120.118.208955223881.341.4651.04991320811.21654274CS
260.3734.25925925931.081.6750.9753174051.22040811CS
52-1.61-52.6143790853.063.880.873671441.48956847CS
156-15.4-91.394658753716.8523.580.871907704.35693397CS
260-15.4-91.394658753716.8523.580.871907704.35693397CS

ANTX - Frequently Asked Questions (FAQ)

What is the current AN2 Therapeutics share price?
The current share price of AN2 Therapeutics is US$ 1,45
How many AN2 Therapeutics shares are in issue?
AN2 Therapeutics has 29.878.890 shares in issue
What is the market cap of AN2 Therapeutics?
The market capitalisation of AN2 Therapeutics is USD 43,62M
What is the 1 year trading range for AN2 Therapeutics share price?
AN2 Therapeutics has traded in the range of US$ 0,87 to US$ 3,88 during the past year
What is the PE ratio of AN2 Therapeutics?
The price to earnings ratio of AN2 Therapeutics is -0,67
What is the reporting currency for AN2 Therapeutics?
AN2 Therapeutics reports financial results in USD
What is the latest annual profit for AN2 Therapeutics?
The latest annual profit of AN2 Therapeutics is USD -64,73M
What is the registered address of AN2 Therapeutics?
The registered address for AN2 Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the AN2 Therapeutics website address?
The website address for AN2 Therapeutics is www.an2therapeutics.com
Which industry sector does AN2 Therapeutics operate in?
AN2 Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PSTVPlus Therapeutics Inc
US$ 1,0489
(105,26%)
127,18M
SAGSAG Holdings Ltd
US$ 1,195
(77,04%)
106,81M
WINTWindtree Therapeutics Inc
US$ 2,76
(63,31%)
103,45M
OPTNOptiNose Inc
US$ 9,28
(54,67%)
1,12M
AEVAAeva Technologies Inc
US$ 4,205
(35,21%)
2,91M
BHILBenson Hill Inc
US$ 0,3941
(-38,94%)
984,55k
ELEVElevation Oncology Inc
US$ 0,29435
(-38,39%)
10,81M
SYRSSyros Pharmaceuticals Inc
US$ 0,081
(-30,89%)
4,87M
ADAPAdaptimmune Therapeutics PLC
US$ 0,3134
(-30,22%)
9,79M
XHLDTEN Holdings Inc
US$ 1,1301
(-28,92%)
10,78M
PSTVPlus Therapeutics Inc
US$ 1,0489
(105,26%)
127,18M
AGMHAGM Group Holdings Inc
US$ 0,07815
(8,54%)
121,05M
SAGSAG Holdings Ltd
US$ 1,195
(77,04%)
106,81M
WINTWindtree Therapeutics Inc
US$ 2,76
(63,31%)
103,45M
NVDANVIDIA Corporation
US$ 119,0893
(1,34%)
91,32M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen